🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This proposal aims to evaluate the safety and efficacy of artemisinin-based...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00297882
Treatments Being Tested
To assess the efficacy of both first-line antimalarial medications used for...
Status
Completed
Location
Sinje Health Center, Garwula District, Sinje, Grand Cape Mount County
Start Date
2022-08-09
Trial ID
NCT06300970
Treatments Being Tested
A longitudinal study with four parallel cohorts with each participant follo...
Status
Recruiting
Location
Baylor- Uganda
Start Date
2025-12-18
Trial ID
NCT06967519
Treatments Being Tested
A partially blinded randomised controlled non-inferiority trial comparing t...
Status
Completed
Location
Ramu Upazilla Health Complex
Start Date
2021-06-30
Trial ID
NCT03939104
Malaria is the most important human parasitic disease and is responsible of...
Status
Completed
Location
ISSR/Centre Muraz
Start Date
2010-06
Trial ID
NCT00852423
The main objective is to compare the safety and efficacy of 4 artemisinin-b...
Status
Completed
Location
Centre Muraz/IRSS
Start Date
2007-07
Trial ID
NCT00393679
A partially blinded randomised controlled non-inferiority trial comparing t...
Status
Completed
Location
Institut des Sciences et Techniques (INSTech)
Start Date
2020-09-01
Trial ID
NCT03923725
Background: Artemisinin resistance has emerged in parts of Southeast Asia, ...
Status
Completed
Location
Kibindu
Start Date
2023-05-01
Trial ID
NCT05764746
This is a classical in vivo clinical trial, following World Health organiza...
Status
Completed
Location
Hospital Rural de Montepuez
Start Date
2011-06
Trial ID
NCT02168569
The purpose of this study is to compare the gametocytocidal and transmissio...
Status
Completed
Location
Malaria Research and Training Centre
Start Date
2022-10-17
Trial ID
NCT05550909
Treatments Being Tested